
Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data
29/1/2026
0:00
29:08
Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases?
Credit available for this activity expires: 1/26/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu
Altri episodi di "Keeping Current CME"



Non perdere nemmeno un episodio di “Keeping Current CME”. Iscriviti all'app gratuita GetPodcast.








